CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE
Clinical trials for CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE trials appear
Sign up with your email to follow new studies for CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New stem cell transplant method aims to cut complications in young blood cancer patients
Disease control Recruiting nowThis pilot study tests a stem cell transplant method that removes specific immune cells (alpha/beta T cells and B cells) from the donor cells before transplant. The goal is to reduce the risk of graft-versus-host disease, a serious complication, while still allowing the transplan…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Nurse-Led checkups could catch leukemia drug side effects sooner
Symptom relief Recruiting nowThis study looks at whether an advanced practice nurse (APN) can help people with chronic myeloid leukemia (CML) by catching mild side effects early. About 60 adults starting or changing oral therapy will be followed. The goal is to see if nurse-led care improves quality of life,…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE
Phase: NA • Sponsor: Centre Hospitalier Henri Duffaut - Avignon • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Massive CML registry launches to reveal how TKIs really perform
Knowledge-focused Recruiting nowThis registry will follow 1,000 adults with chronic-phase CML who are taking approved TKIs (like Gleevec or Tasigna) as their first or second treatment. Over 5 years, researchers will track side effects, treatment changes, and patient-reported experiences to understand how these …
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC